{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:49:03Z","timestamp":1793148543753,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS100744"],"award-info":[{"award-number":["NS100744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21ES027470"],"award-info":[{"award-number":["R21ES027470"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS095387"],"award-info":[{"award-number":["NS095387"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG005133"],"award-info":[{"award-number":["AG005133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael J Fox Foundation"},{"name":"Blechman Foundation"},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nbd.2019.104626","type":"journal-article","created":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T17:05:53Z","timestamp":1570986353000},"page":"104626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-5104","authenticated-orcid":false,"given":"Emily M.","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana R.","family":"De Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan G.","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa G.","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Timothy","family":"Greenamyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.104626_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","article-title":"Alpha galactosidase a activity in Parkinson\u2019s disease","volume":"112","author":"Alcalay","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"6384","key":"10.1016\/j.nbd.2019.104626_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aar5683","article-title":"LRRK2 kinase in Parkinson\u2019s disease","volume":"360","author":"Alessi","year":"2018","journal-title":"Science."},{"issue":"6357","key":"10.1016\/j.nbd.2019.104626_bb0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.nbd.2019.104626_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2019.104626_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am J Pathol."},{"key":"10.1016\/j.nbd.2019.104626_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","article-title":"Selective loss of glucocerebrosidase activity in sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"10","author":"Chiasserini","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.nbd.2019.104626_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104626_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol Brain."},{"key":"10.1016\/j.nbd.2019.104626_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfz082","article-title":"Sex differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson\u2019s disease incidence","volume":"170","author":"De Miranda","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"37","key":"10.1016\/j.nbd.2019.104626_bb0050","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"issue":"342","key":"10.1016\/j.nbd.2019.104626_bb0055","doi-asserted-by":"crossref","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"Alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci Transl Med."},{"issue":"451","key":"10.1016\/j.nbd.2019.104626_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation in idiopathic Parkinson\u2019s disease","volume":"10","author":"Di Maio","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.nbd.2019.104626_bb0065","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/s41598-017-04232-4","article-title":"Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson\u2019s disease","volume":"7","author":"Fang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.104626_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/srep45076","article-title":"Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis","volume":"7","author":"Fernandez-Mosquera","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.nbd.2019.104626_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"issue":"16","key":"10.1016\/j.nbd.2019.104626_bb0080","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1021\/acs.analchem.7b01442","article-title":"Glucosylceramide and glucosylsphingosine quantitation by liquid chromatography-tandem mass spectrometry to enable in vivo preclinical studies of neuronopathic Gaucher disease","volume":"89","author":"Hamler","year":"2017","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2019.104626_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson\u2019s disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"issue":"4","key":"10.1016\/j.nbd.2019.104626_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.yexcr.2009.09.014","article-title":"LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity","volume":"316","author":"Heo","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.nbd.2019.104626_bb0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1042\/BCJ20170699","article-title":"P62\/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity","volume":"475","author":"Kalogeropulou","year":"2018","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.nbd.2019.104626_bb0100","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104626_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2018.05.015","article-title":"Lysosome trafficking and signaling in health and neurodegenerative diseases","volume":"122","author":"Lie","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104626_bb0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2018.05.015","article-title":"Lysosome trafficking and signaling in health and neurodegenerative diseases","volume":"122","author":"Lie","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2019.104626_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BCJ20170802","article-title":"Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson\u2019s disease kinase","volume":"475","author":"Lis","year":"2018","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.nbd.2019.104626_bb0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neuron.2012.11.033","article-title":"RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson\u2019s disease risk","volume":"77","author":"MacLeod","year":"2013","journal-title":"Neuron."},{"issue":"18","key":"10.1016\/j.nbd.2019.104626_bb0125","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"Mak","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.nbd.2019.104626_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson\u2019s disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2019.104626_bb0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tins.2013.11.006","article-title":"Stuck in traffic: an emerging theme in diseases of the nervous system","volume":"37","author":"Neefjes","year":"2014","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2019.104626_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","article-title":"Endosome function and dysfunction in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"26","author":"Nixon","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.nbd.2019.104626_bb0145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","article-title":"Neurodegenerative lysosomal disorders: a continuum from development to late age","volume":"4","author":"Nixon","year":"2008","journal-title":"Autophagy."},{"issue":"21","key":"10.1016\/j.nbd.2019.104626_bb0150","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology."},{"issue":"45","key":"10.1016\/j.nbd.2019.104626_bb0155","doi-asserted-by":"crossref","first-page":"46915","DOI":"10.1074\/jbc.M405146200","article-title":"Stefanis L. alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons","volume":"279","author":"Rideout","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2019.104626_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2019.104626_bb0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"16","key":"10.1016\/j.nbd.2019.104626_bb0170","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J. Neurosci."},{"issue":"6645","key":"10.1016\/j.nbd.2019.104626_bb0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104626_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31012","article-title":"Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis","volume":"6","author":"Steger","year":"2017","journal-title":"Elife."},{"issue":"29","key":"10.1016\/j.nbd.2019.104626_bb0185","doi-asserted-by":"crossref","first-page":"27441","DOI":"10.1074\/jbc.M101318200","article-title":"Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein","volume":"276","author":"Sung","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.nbd.2019.104626_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052868","article-title":"p62\/SQSTM1-dependent autophagy of Lewy body-like alpha-synuclein inclusions","volume":"7","author":"Watanabe","year":"2012","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:14:52Z","timestamp":1760850892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119303018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S0969996119303018"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104626","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104626"}}